Insilico Medicine Convenes an Open Consortium For Benchmark Quality in AI-Driven Drug Discovery
This story is from 2026-08-24. It is preserved in the archive; the latest stories are on the live feed.
Insider Brief PRESS RELEASE Insilico Medicine (“Insilico”; HKEX: 3696), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced the launch of the Open Drug Discovery and Development Consortium (O3DC) www.o3dc.org, an open initiative addressing how com…
Read the full story at AI Insider ↗
Timeline · 1 report
- 2026-08-24 17:27 · AI Insider
Insilico Medicine Convenes an Open Consortium For Benchmark Quality in AI-Driven Drug Discovery
More stories
- Google Joins OpenAI, Anthropic, Meta in Disclosing AI Hacks — Bloomberg AI
- Alibaba ships Qwen3.8-Omni-Flash to watch, listen and call tools — r/LocalLLM
- Introducing Kimi K3 on Amazon Bedrock — AWS Machine Learning Blog
- Introducing Amazon SageMaker HyperPod Inference Gateway — AWS Machine Learning Blog
- Introducing Astra for Law — OpenAI News
- Newsom signs executive order to explore new AI rules, consider ‘kill switch’ — Politico Technology
- Anthropic, OpenAI, SpaceXAI, Google sued over call to ‘pace’ AI development — Politico Technology
- Sources: Anthropic considers releasing a new AI model to counter OpenAI's momentum since Astra's launch, ahead of an IPO and after Amodei's call for a slowdown (Reuters) — Techmeme
Get the daily brief of stories like this at 6:30 every morning →